The observation that only a portion of all alginate-polylysine microca
psules are overgrown after implantation suggests that physical imperfe
ctions of individual capsules, rather than the chemical composition of
the material applied, are responsible for inducing insufficient bioco
mpatibility and thereby fibrotic overgrowth of those capsules. We rece
ntly developed a lectin binding assay that allows for quantifying the
portion of inadequately encapsulated islets, and demonstrated that ina
dequately encapsulated islets induce a fibrotic response associated wi
th graft failure. The present study investigates factors influencing t
he adequacy of encapsulation of pancreatic islets, We applied our lect
in binding assay and found that the number of inadequate, and particul
arly incomplete, capsules is influenced by the following factors. (1)
A capsule diameter of 800 mu m is associated with a lower percentage o
f inadequate capsules than smaller (500 mu m and 600 mu m) or larger (
1800 mu m) capsules. (2) A high rather than low guluronic acid content
of the alginate is associated with a lower percentage of inadequate c
apsules, This can be explained, at least in part, by smaller ranges of
swelling and subsequent shrinkage during the encapsulation procedure.
(3) An increase in viscosity caused by applying a higher alginate con
centration compensates for a low guluronic acid content, This effect o
f increased viscosity cannot be explained by a reduced range of swelli
ng and shrinkage during the encapsulation procedure. We conclude that
alginates with a high guluronic acid content and a viscosity near the
filtration limit are preferable in order to minimize the number of ina
dequate capsules.